Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Hairy Cell × dabrafenib × 1 year × Clear all

Sponsor

Conditions

Melanoma 16 Glioma 6 Thyroid Carcinoma, Anaplastic 5 Carcinoma, Non-Small-Cell Lung 5 Thyroid Neoplasms 4 Neoplasms 4 Neoplasm Metastasis 4 Multiple Myeloma 4 Colorectal Neoplasms 3 Thyroid Cancer, Papillary 2 Skin Neoplasms 2 Histiocytosis, Langerhans-Cell 2 Hematologic Neoplasms 2 Glioblastoma 2 Fever 2 Brain Neoplasms 2 Astrocytoma 2 Thyroid cancer, follicular 1 Thyroid cancer, Hurthle cell 1 Sarcoma 1 Refractory Differentiated Thyroid Gland Carcinoma 1 Recurrence 1 Rectal Neoplasms 1 Rare Malignant Neoplasm 1 Ovarian Neoplasms 1 Oligodendroglioma 1 Neurofibromatosis 1 1 Neurofibroma, Plexiform 1 Neurocytoma 1 Neuroblastoma 1

Interventions

Rituximab 8 Vemurafenib 4 Cladribine 4 obinutuzumab 3 Specimen Handling 3 Cyclophosphamide 3 Biopsy 3 ibrutinib 2 binimetinib 2 Lenalidomide 2 Diphenhydramine 2 CT-P10 2 Bendamustine Hydrochloride 2 Acetaminophen 2 venetoclax 1 tovorafenib 1 polatuzumab vedotin 1 pembrolizumab 1 immunotoxin HA22 1 fludarabine phosphate 1 fludarabine 1 encorafenib 1 cc-486 1 brexucabtagene autoleucel 1 acalabrutinib 1 Valganciclovir 1 Therapeutics 1 Spinal Puncture 1 Sodium Chloride 1 Prednisone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡